Australia Stocks Erase A$18.6b on Emerging Market Contagion Fear
(Bloomberg) -- The S&P/ASX 200 Index fell 1 percent to close at 6,230.40 in Sydney, wiping out A$18.6 billion ($13.4 billion) to extend its longest losing streak in more than three months on concern emerging-market contagion will spill into developed markets and as U.S.-China trade tensions persist.
Sigma Healthcare Ltd. was among the best performers ahead of its first-half results on Thursday. Orocobre Ltd. was the worst after saying that Argentina’s export tax will equate to a levy of about 8% of its local venture’s export sales revenue.
In New Zealand, the NZX 50 index fell 0.7 percent to close at 9,228.00.
- Sigma Healthcare +5.2%; NOTE: down since cutting profit forecast in July
- Reliance Worldwide +3.7%; fell 10% since Aug. 29 as of Tuesday’s close
- Vocus +3.5%
- Orocobre -13%; Orocobre Slides to Lowest in Year After Argentina Export Tax
- Sims Metal Management -5.1%, pares Tuesday’s 7% gain
- Western Areas -4.9%; Nickel Near Lowest This Year as Metals Weaken Again
- Stocks Drop Amid EM Turmoil; Dollar Holds Gains: Markets Wrap
- Australians Spending Like 2007 Drive Fastest Growth in Six Years
- Australia’s Government Scraps Plan to Raise Pension Age to 70
- Emerging-Market Contagion Fear Is Rising as Sell-Off Gets Deeper
- Millennials Down Under Are Sick of Paying for Boomers’ Health
- Rate-Cut Bets Jump in New Zealand as Business Confidence Falls
- Chorus Names Aurizon Executive David Collins as New CFO
- Oceania Healthcare Says Major Holder to Sell 95m Shares
- Deutsche Bank’s Dumas Joins Ardea IM as Portfolio Manager
- Glass Ceiling Intact in Australia Where 7% of CEOs Are Women
- For Australian stocks to watch, check out NI SWAU. Click NI AUSTREET for a wrap of analyst research notes
©2018 Bloomberg L.P.